These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 12796636)

  • 1. Histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications.
    Larson BT; Bostwick DG; Corica AG; Larson TR
    J Urol; 2003 Jul; 170(1):12-9. PubMed ID: 12796636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of transurethral biopsy sampling of the prostate to diagnose prostate cancer in men undergoing surgical intervention for benign prostatic hyperplasia.
    Bales GT; Flynn TJ; Kynaston HG; Golash A; Hart A; Kim HL; Gerber GS
    Tech Urol; 2000 Sep; 6(3):201-4. PubMed ID: 10963487
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Practice patterns in benign prostatic hyperplasia surgical therapy: the dramatic increase in minimally invasive technologies.
    Yu X; Elliott SP; Wilt TJ; McBean AM
    J Urol; 2008 Jul; 180(1):241-5; discussion 245. PubMed ID: 18499180
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Re: histological changes of minimally invasive procedures for the treatment of benign prostatic hyperplasia and prostate cancer: clinical implications.
    Kumar H
    J Urol; 2004 Mar; 171(3):1244. PubMed ID: 14767319
    [No Abstract]   [Full Text] [Related]  

  • 5. [Advances in minimally invasive treatment of benign prostatic hyperplasia].
    Yu B; Wang Z
    Zhonghua Nan Ke Xue; 2007 Aug; 13(8):739-43. PubMed ID: 17918717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Durability and cost-effectiveness of transurethral needle ablation of the prostate as an alternative to transurethral resection of the prostate when alpha-adrenergic antagonist therapy fails.
    Rosario DJ; Phillips JT; Chapple CR
    J Urol; 2007 Mar; 177(3):1047-51; discussion 1051. PubMed ID: 17296409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A clinical outcomes and cost analysis comparing photoselective vaporization of the prostate to alternative minimally invasive therapies and transurethral prostate resection for the treatment of benign prostatic hyperplasia.
    Stovsky MD; Griffiths RI; Duff SB
    J Urol; 2006 Oct; 176(4 Pt 1):1500-6. PubMed ID: 16952668
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A population based study of incidence and treatment of benign prostatic hyperplasia among residents of Olmsted County, Minnesota: 1987 to 1997.
    Sarma AV; Jacobson DJ; McGree ME; Roberts RO; Lieber MM; Jacobsen SJ
    J Urol; 2005 Jun; 173(6):2048-53. PubMed ID: 15879823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast liquid ablation system for prostatic hyperplasia: a new minimally invasive thermal treatment.
    Corica AG; Qian J; Ma J; Sagaz AA; Corica AP; Bostwick DG
    J Urol; 2003 Sep; 170(3):874-8. PubMed ID: 12913720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Minimally invasive therapies for benign prostatic hyperplasia.
    Tunuguntla HS; Evans CP
    World J Urol; 2002 Sep; 20(4):197-206. PubMed ID: 12215846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bloodless management of benign prostatic hyperplasia: medical and minimally invasive treatment options.
    Liatsikos E; Kyriazis I; Kallidonis P; Stolzenburg JU
    Aging Male; 2011 Sep; 14(3):141-9. PubMed ID: 21247241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Surgical innovations in the treatment of benign prostatic hyperplasia: towards new standard treatments?].
    Cornu JN; Rouprêt M
    Prog Urol; 2007 Sep; 17(5 Suppl 1):1026-8. PubMed ID: 17969784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Durability and retreatment rates of minimal invasive treatments of benign prostatic hyperplasia: a cross-analysis of the literature.
    Djavan B; Eckersberger E; Handl MJ; Brandner R; Sadri H; Lepor H
    Can J Urol; 2010 Aug; 17(4):5249-54. PubMed ID: 20735902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term results of contact laser versus transurethral resection of the prostate in the treatment of benign prostatic hyperplasia with small or moderately enlarged prostates.
    Tuhkanen K; Heino A; Aaltomaa S; Ala-Opas M
    Scand J Urol Nephrol; 2003; 37(6):487-93. PubMed ID: 14675922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An evaluation of the economic costs and patient-related consequences of treatments for benign prostatic hyperplasia.
    DiSantostefano RL; Biddle AK; Lavelle JP
    BJU Int; 2006 May; 97(5):1007-16. PubMed ID: 16542339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel resectoscope for transurethral resection of bladder tumors and the prostate.
    Pantuck AJ; Baniel J; Kirkali Z; Klatte T; Zomorodian N; Yossepowitch O; Belldegrun AS
    J Urol; 2007 Dec; 178(6):2331-6; discussion 2336. PubMed ID: 17936809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Minimal invasive therapy of benign prostatic hyperplasia].
    Madersbacher S; Marberger M
    Wien Med Wochenschr; 1996; 146(8):169-75. PubMed ID: 8767402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of benign prostatic hyperplasia syndrome. 2: Interventional therapy].
    Muschter R; Hofstetter A
    MMW Fortschr Med; 2000 Jan; 142(3 Suppl):161-9. PubMed ID: 10783606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment options for benign prostatic hyperplasia in older men.
    Miano R; De Nunzio C; Asimakopoulos AD; Germani S; Tubaro A
    Med Sci Monit; 2008 Jul; 14(7):RA94-102. PubMed ID: 18591930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of lower urinary tract symptoms in benign prostatic hyperplasia and its impact on sexual function.
    Miner M; Rosenberg MT; Perelman MA
    Clin Ther; 2006 Jan; 28(1):13-25. PubMed ID: 16490576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.